A citation-based method for searching scientific literature

Kristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, Ryohei Katayama, Christine M Lovly, Nerina T McDonald, Pierre P Massion, Christina Siwak-Tapp, Adriana Gonzalez, Rong Fang, Eugene J Mark, Julie M Batten, Haiquan Chen, Keith D Wilner, Eunice L Kwak, Jeffrey W Clark, David P Carbone, Hongbin Ji, Jeffrey A Engelman, Mari Mino-Kenudson, William Pao, A John Iafrate. J Clin Oncol 2012
Times Cited: 1002



Kurtis D Davies, Anh T Le, Mariana F Theodoro, Margaret C Skokan, Dara L Aisner, Eamon M Berge, Luigi M Terracciano, Federico Cappuzzo, Matteo Incarbone, Massimo Roncalli, Marco Alloisio, Armando Santoro, D Ross Camidge, Marileila Varella-Garcia, Robert C Doebele. Clin Cancer Res 2012
Times Cited: 283




List of shared articles



Times cited

SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors.
Zong-Jun Xia, Yin-Chun Ji, De-Qiao Sun, Xia Peng, Ying-Lei Gao, Yan-Fen Fang, Xing-Dong Zhao, Wei-Bo Wang, Jian Ding, Mei-Yu Geng,[...]. Acta Pharmacol Sin 2021
1


Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study.
Yongchang Zhang, Xiangyu Zhang, Ruiguang Zhang, Qinqin Xu, Haiyan Yang, Analyn Lizaso, Chunwei Xu, Jun Liu, Wenxian Wang, Sai-Hong Ignatius Ou,[...]. BMC Med 2021
0

ROS1-dependent cancers - biology, diagnostics and therapeutics.
Alexander Drilon, Chelsea Jenkins, Sudarshan Iyer, Adam Schoenfeld, Clare Keddy, Monika A Davare. Nat Rev Clin Oncol 2021
22


Profile of entrectinib in the treatment of ROS1-positive non-small cell lung cancer: Evidence to date.
Jhajaira M Araujo, Andrea C Gomez, Joseph A Pinto, Christian Rolfo, Luis E Raez. Hematol Oncol Stem Cell Ther 2021
1

Simultaneous analysis of ALK, RET, and ROS1 gene fusions by NanoString in Brazilian lung adenocarcinoma patients.
Lázaro Antonio Campanha Novaes, Luciane Sussuchi da Silva, Pedro De Marchi, Rodrigo de Oliveira Cavagna, Flavia Escremim de Paula, Maicon Fernando Zanon, Adriane Feijó Evangelista, Eduardo Caetano Albino da Silva, Vinícius Duval da Silva, Letícia Ferro Leal,[...]. Transl Lung Cancer Res 2021
2

A novel CD74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report.
Huiyu Hu, Nianhua Ding, Haiyan Zhou, Shouman Wang, Lili Tang, Zhi Xiao. J Med Case Rep 2021
0


Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in ROS1+ NSCLC.
Robert C Doebele, Laura Perez, Huong Trinh, Michael Martinec, Reynaldo Martina, Todd Riehl, Matthew G Krebs, Neal J Meropol, William B Wong, Gracy Crane. J Comp Eff Res 2021
0

Deepening the Knowledge of ROS1 Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant Alterations.
Giorgia Guaitoli, Federica Bertolini, Stefania Bettelli, Samantha Manfredini, Michela Maur, Lucia Trudu, Beatrice Aramini, Valentina Masciale, Giulia Grisendi, Massimo Dominici,[...]. Int J Mol Sci 2021
0

Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR.
Karan Seegobin, Umair Majeed, Nathaniel Wiest, Rami Manochakian, Yanyan Lou, Yujie Zhao. Front Oncol 2021
0

Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization.
Richard S P Huang, Derek Smith, Catherine H Le, Wen-Wei Liu, Ellen Ordinario, Chitra Manohar, Michael Lee, Jaya Rajamani, Huan Truong, Jing Li,[...]. Arch Pathol Lab Med 2020
11